Related Experiment Video
Updated: Apr 17, 2026

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
[Dexamethasone affect on the expression of bcl-2 and mTOR genes in T-lymphocytes from healthy donors]
Abstract:
Synthetic glucocorticoids are able to activate apoptosis in the cells by regulating the transcription of the respective genes. Effect of dexamethasone on apoptosis is an established fact. However, its influence on another program of cell death autophagy, is currently unproven. Therefore, in this paper we have analyzed the influence of dexamethasone on the expression of bcl-2 and mTOR genes in T-lymphocytes from healthy donors. The results showed that dexamethasone reduced the expression of bcl-2 and mTOR genes. However, the nature of the effect of dexamethasone on mTOR and bcl-2 expression was different: the expression of bcl-2 gene in the long-term cultivation was maintained at the same reduced level, while the expression of mTOR was first reduced and then increased.
Insights
Dexamethasone, a synthetic glucocorticoid, reduces the expression of bcl-2 and mTOR genes in T-lymphocytes. This study investigates its impact on cell death pathways, specifically autophagy.
Area of Science:
- Immunology
- Molecular Biology
- Cell Death Mechanisms
Background:
- Synthetic glucocorticoids like dexamethasone are known to induce apoptosis (programmed cell death).
- The effect of dexamethasone on autophagy, another critical cell death pathway, remains largely uninvestigated.
- Understanding these pathways is crucial for immune system regulation and disease treatment.
Purpose of the Study:
- To investigate the influence of dexamethasone on the expression of bcl-2 and mTOR genes in T-lymphocytes.
- To explore the potential role of dexamethasone in modulating autophagy in human T-cells.
Main Methods:
- T-lymphocytes were isolated from healthy donors.
- Cells were treated with dexamethasone.
- Gene expression levels of bcl-2 and mTOR were analyzed.
Main Results:
- Dexamethasone significantly reduced the expression of both bcl-2 and mTOR genes in T-lymphocytes.
- The reduction in bcl-2 expression was sustained during long-term cultivation.
- mTOR expression initially decreased but subsequently increased following dexamethasone treatment.
Conclusions:
- Dexamethasone differentially affects the expression of bcl-2 and mTOR in T-lymphocytes.
- These findings suggest a complex regulatory role for dexamethasone in T-cell survival and death pathways, potentially impacting autophagy.
- Further research is warranted to elucidate the precise mechanisms and functional consequences of these gene expression changes.

